Laboratory Corporation of America Holdings (LH) stock price, revenue, and financials

Laboratory Corporation of America Holdings market cap is $21.8 b, and annual revenue was $11.55 b in FY 2019

$21.8 B

LH Mkt cap, 15-Jan-2021

$3.9 B

Laboratory Corporation of America Holdings Revenue Q3, 2020
Laboratory Corporation of America Holdings Gross profit (Q3, 2020)1.6 B
Laboratory Corporation of America Holdings Gross profit margin (Q3, 2020), %40%
Laboratory Corporation of America Holdings Net income (Q3, 2020)703.7 M
Laboratory Corporation of America Holdings EBIT (Q3, 2020)1 B
Laboratory Corporation of America Holdings Cash, 30-Sept-2020667.2 M
Laboratory Corporation of America Holdings EV27.8 B

Laboratory Corporation of America Holdings Revenue

Laboratory Corporation of America Holdings revenue was $11.55 b in FY, 2019

Embed Graph

Laboratory Corporation of America Holdings Revenue Breakdown

Embed Graph

Laboratory Corporation of America Holdings revenue breakdown by business segment: 69.9% from LCD and 30.1% from CDD

Laboratory Corporation of America Holdings Income Statement

Annual

USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.0b5.5b5.7b5.8b6.0b8.5b9.4b10.2b11.3b11.6b

Revenue growth, %

4%44%11%

Cost of goods sold

2.9b3.3b3.4b3.6b3.8b5.6b6.3b6.7b8.2b8.3b

Gross profit

2.1b2.3b2.2b2.2b2.2b2.9b3.2b3.5b3.2b3.3b

Gross profit Margin, %

42%41%40%38%37%34%34%34%28%28%

General and administrative expense

1.0b1.2b1.1b1.1b1.2b1.6b1.6b1.8b1.6b1.6b

Operating expense total

1.1b1.3b1.2b1.1b1.3b1.9b1.9b2.1b1.9b1.9b

Depreciation and amortization

76.7m164.5m179.5m216.5m231.7m243.2m

EBIT

978.8m948.4m1.0b910.4m1.0b1.3b1.4b1.3b1.3b

EBIT margin, %

20%17%18%15%12%14%13%12%12%

Interest expense

70.0m87.5m94.5m109.5m

Investment income

1.1m1.3m1.0m1.1m1.9m1.7m2.1m7.5m8.8m

Pre tax profit

876.1m834.0m909.0m915.6m758.6m599.6m914.0m891.8m937.7m784.4m

Income tax expense

344.0m333.0m359.4m340.2m314.1m294.1m372.3m(139.1m)384.4m250.8m

Net Income

558.2m519.7m583.1m575.4m511.2m436.9m732.1m1.3b883.7m823.8m

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

1.2b1.2b1.3b1.4b1.4b1.4b1.4b1.4b1.4b1.4b1.5b1.5b1.4b1.5b1.6b1.8b2.2b2.3b2.3b2.4b2.4b2.4b2.5b2.6b2.8b2.9b2.8b2.8b2.9b2.9b2.8b2.8b3.9b

Cost of goods sold

686.7m704.8m748.8m800.0m815.1m836.0m847.2m843.9m863.3m868.7m890.9m914.6m913.9m947.8m980.6m1.2b1.4b1.5b1.5b1.6b1.6b1.6b1.6b1.7b2.1b2.0b2.0b2.0b2.1b2.1b2.1b2.0b2.3b

Gross profit

506.9m533.6m527.7m568.4m588.2m568.5m576.1m579.5m556.1m572.2m577.3m547.6m516.8m568.6m571.2m596.0m774.6m762.9m777.3m826.8m788.4m803.6m861.8m882.8m779.0m835.1m789.9m789.7m824.8m817.3m728.0m760.5m1.6b

Gross profit Margin, %

42%43%41%42%42%40%40%41%39%40%39%37%36%37%37%34%35%34%34%35%33%33%34%34%27%29%28%28%29%28%26%27%40%

R&D expense

3.0m3.0m

General and administrative expense

246.0m245.4m270.5m282.8m322.7m283.8m271.2m279.5m285.1m283.2m280.9m279.0m284.9m297.9m305.7m415.1m392.4m382.5m411.9m408.0m400.5m419.4m435.3m465.3m397.0m395.2m381.8m393.8m415.3m401.5m395.5m396.3m419.5m

Operating expense total

272.7m263.1m292.4m332.6m362.5m329.1m289.0m303.5m311.0m310.2m308.0m303.0m313.5m321.9m329.8m434.4m453.3m456.0m475.4m459.9m464.4m470.9m525.8m541.5m473.6m465.9m446.5m471.5m489.1m477.4m920.6m462.8m512.3m

Depreciation and amortization

17.4m20.3m21.0m22.0m18.3m31.4m46.6m47.1m44.3m45.3m41.1m47.6m51.4m54.6m62.3m58.5m54.7m57.1m60.2m61.7m62.3m60.1m62.2m

EBIT

234.2m270.5m235.3m235.8m225.7m239.4m287.1m276.0m245.1m262.0m269.3m244.6m203.3m246.7m241.4m321.3m306.9m301.9m366.9m324.0m332.7m336.0m341.3m305.4m369.2m343.4m318.2m335.7m339.9m(192.6m)297.7m1.0b

EBIT margin, %

20%22%18%17%16%17%20%19%17%18%18%17%14%16%16%14%14%13%15%14%14%13%13%11%13%12%11%12%12%(7%)11%27%

Interest expense

14.6m14.5m21.6m24.0m21.0m20.3m21.5m21.3m24.1m24.5m23.1m15.6m63.5m52.7m

Investment income

300.0k200.0k300.0k300.0k200.0k200.0k200.0k200.0k300.0k200.0k200.0k1.8m200.0k400.0k300.0k600.0k300.0k400.0k500.0k400.0k600.0k300.0k400.0k700.0k600.0k800.0k2.8m600.0k1.4m2.9m2.6m2.5m2.6m

Income tax expense

86.9m102.8m73.5m83.1m80.6m82.5m107.6m102.4m78.5m93.8m97.7m81.3m74.2m90.8m81.5m29.3m95.6m97.3m95.5m114.8m83.6m87.2m96.2m97.7m69.0m78.6m180.6m68.8m79.3m66.4m49.2m65.4m243.4m

Net Income

136.2m153.7m140.0m127.1m122.9m134.3m161.6m153.3m148.0m147.2m151.9m148.3m113.1m141.3m137.2m700.0k168.4m152.8m160.2m198.2m179.5m192.2m188.6m180.6m173.2m233.8m318.8m185.6m190.4m220.7m(316.9m)231.6m703.7m

Laboratory Corporation of America Holdings Balance Sheet

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

172.2m103.8m96.9m195.4m118.9m85.8m129.9m124.4m466.0m185.8m111.3m174.1m338.9m479.5m575.7m446.4m619.0m713.0m696.3m639.6m567.6m365.5m299.9m409.3m361.8m221.4m892.6m348.8m265.4m361.1m323.6m667.2m

Accounts Receivable

614.3m617.6m631.0m717.3m714.8m718.7m751.7m735.8m768.9m793.8m815.7m813.2m822.0m832.6m841.6m1.2b1.2b1.2b1.3b1.3b1.3b1.4b1.4b1.6b1.6b1.5b1.5b1.6b1.6b1.6b1.5b

Prepaid Expenses

74.3m69.0m68.7m71.8m64.4m78.4m69.8m68.1m78.2m67.4m75.3m79.9m125.2m115.2m126.3m319.8m387.3m378.3m360.1m297.2m325.6m343.1m379.3m450.2m347.0m286.1m292.5m317.1m298.6m297.7m353.2m317.5m327.2m

Inventories

82.5m86.3m88.2m98.0m106.8m103.8m107.0m114.0m118.9m124.0m126.4m126.5m134.8m134.5m138.8m186.5m182.0m181.6m188.2m189.6m198.8m199.8m209.9m217.2m226.2m230.7m233.0m233.7m219.7m234.9m342.3m392.5m

Current Assets

981.0m915.8m948.7m1.1b1.1b1.1b1.1b1.1b1.5b1.2b1.1b1.2b1.4b1.6b1.7b2.3b2.6b2.7b2.7b2.6b2.7b2.5b2.5b2.9b2.9b3.0b3.3b2.9b2.8b3.0b2.9b3.4b4.1b

PP&E

488.4m499.1m504.6m579.5m586.4m577.4m577.2m576.2m612.2m634.6m646.9m672.6m733.1m741.2m754.7m1.6b1.8b1.8b1.8b1.7b1.7b1.7b1.7b1.7b1.7b1.7b1.7b2.5b2.5b2.5b2.6b2.6b2.6b

Goodwill

1.9b2.0b2.0b2.6b2.6b2.6b2.7b2.7b2.9b2.9b3.0b3.0b3.1b3.1b3.1b6.3b6.1b6.1b6.3b6.2b6.4b6.5b6.6b7.3b7.6b7.4b7.4b7.4b7.8b7.8b7.4b7.4b7.6b

Total Assets

4.9b5.0b5.0b6.2b6.2b6.1b6.1b6.1b6.8b6.6b6.6b6.7b7.0b7.1b7.2b14.2b14.5b14.4b14.4b14.2b14.5b14.4b14.9b16.7b16.8b16.5b16.7b17.0b17.7b17.8b17.3b17.8b18.7b

Accounts Payable

169.3m195.4m177.1m215.4m212.5m222.9m225.7m234.5m247.4m246.6m253.4m262.0m281.9m280.6m286.2m420.8m438.8m445.0m466.0m443.5m454.8m484.9m491.7m595.4m519.1m488.1m497.5m592.2m531.6m607.8m568.7m534.1m639.5m

Short-term debt

370.0m383.4m425.4m396.8m215.1m214.3m136.0m134.4m485.1m147.9m119.9m110.4m105.3m97.6m97.6m348.6m674.1m674.7m425.4m87.4m698.2m519.6m18.1m417.7m417.8m417.8m501.7m502.3m502.6m620.1m986.1m570.4m

Current Liabilities

886.4m895.6m951.3m1.2b1.0b982.2m769.2m718.5m1.1b740.5m655.1m680.6m753.6m740.8m749.0m1.4b1.8b1.8b1.6b1.3b1.9b1.8b1.8b1.5b2.1b2.1b2.1b2.5b2.5b2.6b3.0b3.0b

Long-term debt

958.3m939.4m920.6m1.8b1.8b1.8b2.0b2.0b2.2b2.2b2.4b2.6b2.9b2.9b2.9b6.6b6.1b6.0b6.0b6.0b5.5b5.4b5.6b7.2b6.4b6.0b6.0b6.0b632.3m6.2b6.5b6.1b6.1b

Total Debt

1.3b1.3b1.3b2.2b2.0b2.0b2.1b2.1b2.7b2.3b2.5b110.4m105.3m97.6m97.6m348.6m674.1m674.7m6.4b6.1b6.2b5.4b6.1b7.2b6.8b6.5b6.5b6.5b1.1b6.7b7.1b7.1b6.7b

Total Liabilities

2.8b2.7b2.8b3.8b3.6b3.5b3.5b3.4b4.1b3.8b3.9b4.1b4.5b4.5b4.4b9.6b9.7b9.5b9.2b8.9b8.9b8.8b9.0b10.5b9.8b9.4b9.4b9.8b10.3b10.5b10.5b

Common Stock

12.4m12.3m12.1m12.0m12.1m11.9m11.6m11.5m11.4m11.2m11.0m10.7m10.4m10.4m10.4m12.0m12.0m12.0m12.0m12.1m12.1m12.1m12.0m12.0m12.0m12.0m11.9m11.6m9.1m

Additional Paid-in Capital

17.7m72.7m1.8b1.9b1.9b2.0b2.1b2.1b2.1b2.0b2.0b2.0b1.9b1.8b1.4b91.4m47.8m32.1m80.7m

Retained Earnings

3.0b3.1b3.1b3.2b3.3b3.4b3.5b3.5b3.6b3.7b3.6b3.5b3.4b3.6b3.7b3.8b4.0b4.1b4.4b4.6b4.8b5.1b5.3b5.5b6.4b6.6b6.9b7.3b7.5b7.7b7.8b

Total Equity

2.2b2.2b2.3b2.4b2.6b2.5b2.6b2.6b2.7b2.8b2.7b2.6b2.5b2.7b2.8b4.5b4.8b4.9b5.2b5.3b5.5b5.7b5.9b6.1b7.0b7.0b7.2b7.1b7.1b7.2b7.0b7.4b8.2b

Debt to Equity Ratio

0 x0 x0 x0 x0.1 x0.1 x0.1 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

2.3 x2.2 x2.2 x2.6 x2.4 x2.4 x2.4 x2.3 x2.5 x2.4 x2.5 x2.6 x2.8 x2.7 x2.6 x3.1 x3 x2.9 x2.8 x2.7 x2.6 x2.6 x2.5 x2.7 x2.4 x2.3 x2.3 x2.4 x2.5 x2.5 x2.5 x2.4 x2.3 x

Laboratory Corporation of America Holdings Cash Flow

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

136.2m286.4m426.4m127.1m250.0m384.3m161.6m314.9m462.9m147.2m299.2m448.7m113.5m255.2m392.7m1.0m170.3m323.5m160.2m359.0m548.6m192.5m381.4m564.8m172.5m406.6m725.7m185.9m376.6m597.6m(316.9m)

Depreciation and Amortization

50.0m100.1m150.7m58.1m115.9m173.6m56.7m112.8m170.4m55.5m112.4m170.3m60.7m123.5m182.0m104.7m223.1m344.5m122.4m247.8m368.9m128.1m255.1m388.2m142.8m281.3m414.4m137.3m277.1m421.4m144.6m

Accounts Receivable

38.4m37.0m49.0m68.5m58.4m(65.9m)(50.5m)(35.0m)(49.2m)(75.8m)(99.7m)(95.5m)(39.2m)(48.0m)(59.7m)(40.3m)(53.8m)(89.9m)(105.8m)(99.6m)(109.2m)(27.9m)(35.4m)(83.0m)(53.6m)13.2m(8.5m)(90.8m)(91.1m)(144.3m)46.7m

Inventories

(7.7m)(3.8m)(2.3m)(5.6m)2.7m(900.0k)3.9m(3.3m)(4.3m)(3.2m)(5.7m)(5.6m)2.9m3.4m(1.3m)4.2m9.5m9.6m2.4m600.0k(4.8m)4.9m(700.0k)(6.4m)1.4m(4.7m)(8.8m)3.4m(1.7m)(14.5m)(10.6m)

Accounts Payable

(14.8m)9.1m(8.9m)(42.6m)(57.3m)(40.8m)(32.3m)(23.3m)(19.4m)10.1m16.9m25.2m(27.1m)(25.7m)(16.2m)(48.9m)(33.8m)(24.3m)(34.1m)(54.3m)(56.3m)(28.0m)(29.0m)29.6m(59.8m)(91.3m)(79.9m)(28.8m)(28.2m)(56.5m)

Cash From Operating Activities

232.0m448.2m624.4m215.3m400.2m577.0m197.1m383.4m587.2m198.2m335.8m570.0m142.3m349.7m525.3m(86.9m)309.8m597.8m123.0m466.6m727.0m233.8m544.5m895.4m154.7m522.0m819.0m165.8m419.3m874.9m203.8m

Purchases of PP&E

(24.5m)(59.0m)(93.3m)(29.4m)(75.2m)(115.6m)(34.2m)(68.3m)(112.4m)(41.7m)(90.5m)(142.6m)(56.5m)(104.6m)(157.2m)(33.8m)(102.9m)(170.7m)(71.4m)(138.4m)(204.6m)(72.2m)(141.5m)(216.8m)(72.5m)(159.7m)(79.1m)(94.2m)(179.4m)(852.9m)(106.6m)

Cash From Investing Activities

(56.5m)(233.9m)(322.5m)(44.5m)(117.3m)(159.0m)(36.2m)(101.6m)(412.3m)(61.5m)(199.6m)(246.8m)(108.1m)(147.2m)(202.8m)(3.7b)(3.8b)(3.9b)(151.6m)(258.4m)(576.1m)(245.5m)(736.9m)(2.1b)(74.3m)(196.3m)353.6m(140.5m)(891.3m)(106.6m)

Short-term Borrowings

(1.3b)(214.7m)(394.7m)(449.2m)(384.5m)(151.7m)

Long-term Borrowings

(132.5m)(25.0m)(37.5m)(18.7m)(37.5m)(56.2m)(30.0m)(40.0m)(200.0k)(600.0k)(251.2m)(312.2m)(313.3m)(1.5m)(328.0m)(331.0m)(2.3m)(4.3m)(506.0m)(2.8m)(5.1m)(6.8m)(3.0m)(6.7m)(10.9m)

Dividends Paid

(2.8m)(5.8m)(8.5m)(1.8m)(2.7m)(5.8m)(300.0k)(700.0k)(900.0k)(300.0k)(400.0k)(600.0k)(300.0k)(600.0k)(900.0k)(1.3m)(1.6m)(1.7m)(300.0k)(500.0k)(800.0k)(5.6m)(5.9m)(6.1m)(200.0k)(500.0k)(800.0k)

Cash From Financing Activities

(152.9m)(258.4m)(353.6m)(207.1m)(394.9m)(561.6m)(191.6m)(316.7m)129.9m(412.8m)(486.9m)(613.7m)(98.0m)(123.4m)(141.8m)3.6b3.5b3.4b3.9m(297.9m)(301.7m)(59.8m)46.9m1.1b(40.0m)(413.0m)(587.0m)(103.2m)311.7m196.7m(102.8m)

Net Change in Cash

23.7m(44.7m)(51.6m)(35.3m)(111.8m)(144.9m)(29.4m)(34.9m)306.7m(281.0m)(355.5m)(292.7m)(65.1m)75.5m171.7m(133.6m)39.0m133.0m(20.1m)(76.8m)(148.8m)(68.1m)(133.7m)(24.3m)45.1m(95.2m)576.0m(78.0m)(161.4m)(65.7m)(13.9m)

Income Taxes Paid

155.7m265.2m7.5m148.4m225.4m8.4m163.7m232.6m11.1m164.3m

Laboratory Corporation of America Holdings Ratios

USDQ1, 2010

Financial Leverage

2.3 x

Laboratory Corporation of America Holdings Operating Metrics

FY, 2016

Countries

60

Patient Service Centers

1.75 k